← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #579 OF 1,000 MOST-CITED

Records - ret'nd dietary supplement: material review, dispos

FDA cited this observation 32 times across 27 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods32
BY FISCAL YEAR
FY20242
FY20236
FY20221
FY20213
FY20202
FY20196
FY20188
FY20174

How FDA worded it — real examples

You did not make and keep records of a material review and disposition decision on a returned dietary supplement.

Prince of Peace Enterprises, Inc. · Livermore, California · Foods · 2024-07-09

You did not make and keep records of a material review and disposition decision on a returned dietary supplement.

Santa Rosa de Lima, Inc. · Mint Hill, North Carolina · Foods · 2024-03-14

You did not make and keep records of a material review and disposition decision on a returned dietary supplement.

Pharmaganics LLC · Plymouth, Minnesota · Foods · 2023-09-05

You did not make and keep records of a material review and disposition decision on a returned dietary supplement.

DYNAMIC TECHNICAL FORMULATIONS LLC · Alpharetta, Georgia · Foods · 2023-08-22

You did not make and keep records of a material review and disposition decision on a returned dietary supplement.

ZeaVision Holdings, Inc. · Chesterfield, Missouri · Foods · 2023-05-18

You did not make and keep records of a material review and disposition decision on a returned dietary supplement.

NeuroScience Solutions, Inc. · Osceola, Wisconsin · Foods · 2023-04-25

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Food industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →